32 results
8-K
EX-99.1
RGLS
Regulus Therapeutics Inc
21 Mar 24
Regulus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Updates
4:18pm
2026.
Research and Development (R&D) Expenses: Research and development expenses were $5.8 million and $21.2 million for the fourth quarter and year
8-K
EX-99.1
RGLS
Regulus Therapeutics Inc
9 Nov 23
Regulus Therapeutics Reports Third Quarter 2023 Financial Results and Recent Updates
4:15pm
in the first quarter of 2024.”
Program Updates
RGLS8429 for ADPKD: The Company held a virtual R&D Day on September 6, 2023, where the executive team joined … investments.
Research and Development (R&D) Expenses: Research and development expenses were $5.5 million and $15.4 million for the three and nine months
8-K
EX-99.1
RGLS
Regulus Therapeutics Inc
8 Aug 23
Regulus Therapeutics Reports Second Quarter 2023 Financial Results and Recent Updates
4:15pm
with Autosomal Dominant Polycystic Kidney Disease
(ADPKD) in Phase 1b Multiple-Ascending Dose (MAD) study of RGLS8429
R&D Day to discuss our ADPKD … ., who are already making meaningful contributions to Regulus and our R&D efforts. Lastly, we continue to be excited by the progress in our preclinical
8-K
EX-99.1
krk8u fjl
11 May 23
Regulus Therapeutics Reports First Quarter 2023 Financial Results and Recent Updates
4:16pm
8-K
EX-99.1
90dacazr5zm8td9
10 Nov 22
Regulus Therapeutics Reports Third Quarter 2022 Financial Results and Recent Updates
4:15pm
8-K
EX-99.1
a2en 2wmzt11b6
11 Aug 22
Regulus Therapeutics Reports Second Quarter 2022 Financial Results and Recent Updates
4:33pm
8-K
EX-99.1
f4r5u
12 May 22
Regulus Therapeutics Reports First Quarter 2022 Financial Results and Recent Updates
4:31pm
8-K
EX-99.1
kbcpvnf
10 Mar 22
Regulus Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Updates
4:31pm
8-K
EX-99.1
ex8ghopi z2yvg
10 Nov 21
Regulus Therapeutics Reports Third Quarter 2021 Financial Results and Recent Updates
4:36pm
8-K
EX-99.1
ie8x5o
10 Aug 21
Regulus Therapeutics Reports Second Quarter 2021 Financial Results and Recent Updates
4:16pm
8-K
EX-99.1
dziv7ene7yjyape0qkv
13 May 21
Regulus Therapeutics Reports First Quarter 2021 Financial Results and Recent Updates
4:15pm
8-K
EX-99.1
o77z0uu67
9 Mar 21
Regulus Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Recent Updates
4:30pm
8-K
EX-10.1
5wxe dkkjstgxck1b3kt
4 Dec 20
Regulus Therapeutics Announces Private Placement of Equity
4:18pm
8-K
EX-99.1
68oqrryibqu1kj6
5 Nov 20
Regulus Therapeutics Reports Third Quarter 2020 Financial Results and Recent Updates
4:32pm
8-K
EX-99.1
9lpedz6s9fb9d04
13 Aug 20
Regulus Therapeutics Reports Second Quarter 2020 Financial Results and Recent Updates
4:30pm
8-K
EX-99.1
1o8iijhmlxruu096
14 May 20
Regulus Therapeutics Reports First Quarter 2020 Financial Results and Recent Updates
4:30pm
8-K
EX-99.1
4k1b1i volp6
12 Mar 20
Regulus Reports Fourth Quarter andYear-End 2019 Financial Results and Recent Updates
4:16pm
8-K
EX-99.1
scnz5
12 Nov 19
Regulus Therapeutics Reports Third Quarter 2019 Financial Results and Recent Updates
4:15pm